Gut microbiota–derived trimethylamine‐N‐oxide protects pulmonary vascular barrier integrity via Vav guanine nucleotide exchange factor 3 (VAV3)‐mediated cytoskeletal remodelling in acute lung injury
British Journal of Pharmacology · 2026-08 · 183 (15) · 4163-4177
DOI: 10.1111/bph.70449 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, online erschienen am 23.04.2026. Verfasst von Xilong Wang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Methylamines, Proto-Oncogene Proteins c-vav, Acute Lung Injury, Gastrointestinal Microbiome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangdong Outstanding Young Scientist Funding, Science and Technology Program of Guangzhou, China.
Abstract (Originalsprache)
Background and Purpose Acute respiratory distress syndrome (ARDS) and acute lung injury (ALI) are characterised by increased pulmonary capillary permeability, but lack effective pharmacotherapies. Emerging evidence implicates gut–lung axis dysregulation in ARDS pathogenesis through microbiome–host interactions, but the specific role of the microbiota‐derived metabolite, trimethylamine‐N‐oxide (TMAO), remains unclear. Experimental Approach Plasma TMAO and hypersensitive C‐reactive protein (hs‐CRP) levels were measured in ARDS patients and healthy controls. A lipopolysaccharide (LPS)‐induced ALI mouse model was employed to evaluate the effects of TMAO administration versus the inhibition of its gut microbiome–derived synthesis. In vitro, the necessity of VAV3 in the mechanism of TMAO was confirmed using gene knockdown techniques to assess endothelial barrier integrity. Key Results Plasma TMAO levels were significantly elevated in ARDS patients compared with healthy controls, and showed a positive correlation with hs‐CRP. In the murine ALI model, TMAO administration reduced lung vascular leakage and neutrophil infiltration, whereas inhibiting its synthesis worsened the injury. Mechanistically, TMAO enhances the integrity of the endothelial barrier by up‐regulating VAV3, which in turn drives Rac1‐dependent cortical actin reorganisation. Knockdown of VAV3 abolished the protective effects of TMAO on the endothelial barrier integrity. Conclusion and Implications This study identifies TMAO as an adaptive mediator within the gut–lung axis that mitigates pulmonary vascular hyperpermeability. The protective mechanism operates via the VAV3–Rac1–cytoskeletal signalling pathway, highlighting the therapeutic potential of TMAO in ALI/ARDS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
- State Key Laboratory of Respiratory Diseases, Guangdong Key Laboratory of Vascular Diseases, Guangzhou Institute of Respiratory Health, Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital o…
- Department of Pulmonary and Critical Care Medicine, The Tenth Affiliated Hospital of Southern Medical University (Dongguan People's Hospital), Dongguan, Guangdong, China.
ORCID-Profile: Weiyong Zeng
Förderung
- National Natural Science Foundation of China
- Guangdong Outstanding Young Scientist Funding
- Science and Technology Program of Guangzhou, China
- R&D Program of Guangzhou National Laboratory
- Dongguan Science and Technology of Social Development Program
Zitieren
APA
Wang, X., Zeng, W., Bai, Q., Zhong, K., Luo, Q., Deng, J., Cen, C., Wang, K., Li, R., Li, J., Zhang, J., Ye, T., Fang, N., Chen, X., & Wang, T. (2026). Gut microbiota–derived trimethylamine‐N‐oxide protects pulmonary vascular barrier integrity via Vav guanine nucleotide exchange factor 3 (VAV3)‐mediated cytoskeletal remodelling in acute lung injury. British Journal of Pharmacology, 183(15), 4163-4177. https://doi.org/10.1111/bph.70449
Vancouver
Wang X, Zeng W, Bai Q, Zhong K, Luo Q, Deng J, et al. Gut microbiota–derived trimethylamine‐N‐oxide protects pulmonary vascular barrier integrity via Vav guanine nucleotide exchange factor 3 (VAV3)‐mediated cytoskeletal remodelling in acute lung injury. British Journal of Pharmacology. 2026;183(15):4163-4177. doi:10.1111/bph.70449
BibTeX
@article{Wang2026,
author = {Wang, Xilong and Zeng, Weiyong and Bai, Qianwen and Zhong, Kai and Luo, Qiao and Deng, Jia and Cen, Chunxian and Wang, Kai and Li, Rui and Li, Jiehong and Zhang, Jingyi and Ye, Tiaofei and Fang, Nianxin and Chen, Xin and Wang, Tao},
title = {Gut microbiota–derived trimethylamine‐N‐oxide protects pulmonary vascular barrier integrity via Vav guanine nucleotide exchange factor 3 (VAV3)‐mediated cytoskeletal remodelling in acute lung injury},
journal = {British Journal of Pharmacology},
year = {2026},
volume = {183},
number = {15},
pages = {4163--4177},
doi = {10.1111/bph.70449}
}
EUVIMED